Brighton Jones LLC’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $984K | Buy |
+3,360
| New | +$1.1M | 0.02% | 465 |
|
|
2025
Q4 | – | Sell |
-4,628
| Closed | -$1.5M | – | 312 |
|
|
2025
Q3 | $1.5M | Buy |
4,628
+1,605
| +53% | +$499K | 0.04% | 284 |
|
|
2025
Q2 | $1.18M | Sell |
3,023
-154
| -5% | -$61.9K | 0.03% | 291 |
|
|
2025
Q1 | $1.38M | Sell |
3,177
-166
| -5% | -$66.6K | 0.04% | 216 |
|
|
2024
Q4 | $1.23M | Sell |
3,343
-9
| -0.3% | -$3.77K | 0.04% | 224 |
|
|
2024
Q3 | $1.74M | Sell |
3,352
-643
| -16% | -$344K | 0.07% | 150 |
|
|
2024
Q2 | $2.16M | Buy |
3,995
+9
| +0.2% | +$4.76K | 0.07% | 140 |
|
|
2024
Q1 | $2.07M | Buy |
3,986
+38
| +1% | +$18.9K | 0.07% | 144 |
|
|
2023
Q4 | $1.86M | Sell |
3,948
-3
| -0.1% | -$1.39K | 0.08% | 142 |
|
|
2023
Q3 | $1.72M | Sell |
3,951
-235
| -6% | -$107K | 0.09% | 133 |
|
|
2023
Q2 | $1.86M | Buy |
4,186
+98
| +2% | +$45.2K | 0.09% | 129 |
|
|
2023
Q1 | $1.88M | Buy |
4,088
+25
| +0.6% | +$11.9K | 0.11% | 121 |
|
|
2022
Q4 | $2.08M | Sell |
4,063
-571
| -12% | -$290K | 0.12% | 99 |
|
|
2022
Q3 | $2.1M | Sell |
4,634
-196
| -4% | -$93.8K | 0.12% | 91 |
|
|
2022
Q2 | $2.33M | Sell |
4,830
-26
| -0.5% | -$12.9K | 0.14% | 89 |
|
|
2022
Q1 | $2.38M | Buy |
4,856
+87
| +2% | +$39.8K | 0.11% | 96 |
|
|
2021
Q4 | $2.21M | Buy |
4,769
+29
| +0.6% | +$12.2K | 0.1% | 99 |
|
|
2021
Q3 | $1.77M | Sell |
4,740
-24
| -0.5% | -$9.12K | 0.09% | 101 |
|
|
2021
Q2 | $1.82M | Buy |
4,764
+22
| +0.5% | +$8.41K | 0.09% | 99 |
|
|
2021
Q1 | $1.7M | Sell |
4,742
-38
| -0.8% | -$12.2K | 0.1% | 95 |
|
|
2020
Q4 | $1.53M | Sell |
4,780
-4
| -0.1% | -$1.23K | 0.09% | 96 |
|
|
2020
Q3 | $1.28M | Buy |
4,784
+51
| +1% | +$13.7K | 0.09% | 94 |
|
|
2020
Q2 | $1.25M | Sell |
4,733
-29
| -0.6% | -$7.74K | 0.1% | 88 |
|
|
2020
Q1 | $1.08M | Buy |
4,762
+53
| +1% | +$14.4K | 0.11% | 88 |
|
|
2019
Q4 | $1.42M | Buy |
4,709
+548
| +13% | +$151K | 0.15% | 88 |
|
|
2019
Q3 | $999K | Sell |
4,161
-74
| -2% | -$20.3K | 0.12% | 101 |
|
|
2019
Q2 | $1.2M | Buy |
4,235
+3,153
| +291% | +$861K | 0.14% | 91 |
|
|
2019
Q1 | $311K | Buy |
1,082
+39
| +4% | +$11.3K | 0.04% | 218 |
|
|
2018
Q4 | $274K | Buy |
1,043
+50
| +5% | +$13.7K | 0.04% | 205 |
|
|
2018
Q3 | $272K | Buy |
993
+1
| +0.1% | +$260 | 0.03% | 215 |
|
|
2018
Q2 | $236K | Buy |
+992
| New | +$230K | 0.03% | 262 |
|
|
2015
Q3 | – | Sell |
-1,605
| Closed | -$263K | – | 198 |
|
|
2015
Q2 | $263K | Sell |
1,605
-82
| -5% | -$13.1K | 0.06% | 149 |
|
|
2015
Q1 | $260K | Buy |
1,687
+45
| +3% | +$6.41K | 0.06% | 154 |
|
|
2014
Q4 | $206K | Buy |
+1,642
| New | +$203K | 0.05% | 184 |
|
Other funds holding ELV
VCM
VPM
Brighton Jones LLC's ELV Position: Q1 2026 in Review
Brighton Jones LLC opened a new position in Elevance Health (ELV) in Q1 2026: 3,360 shares worth $984K. The stake represents 0.02% of the portfolio and ranks #465 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in ELV as recently as Q3 2025.
Brighton Jones LLC first reported a position in ELV in Q4 2014 and has held it in 34 quarters since. The position peaked at $2.38M in Q1 2022. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Brighton Jones LLC held 3,360 shares of Elevance Health worth $984K as of Q1 2026.
- Elevance Health was a new Brighton Jones LLC position in Q1 2026.
- Elevance Health made up 0.02% of Brighton Jones LLC's portfolio in Q1 2026, its #465 holding.
- Brighton Jones LLC first reported a position in Elevance Health in Q4 2014 and has held it in 34 quarters since.
- Brighton Jones LLC's Elevance Health position peaked at $2.38M in Q1 2022.
- 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.